Aptinyx Chief Scientific Officer Joseph Moskal, Ph.D. Named Fellow by National Academy of Inventors and the American Institute for Medical and Biological Engineering

Evanston, Ill., Feb. 21, 2017 /PRNewswire/ -- Aptinyx Inc., a biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced that Joseph Moskal, , chief scientific officer, has been…
Continue Reading »